{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:41:45Z","timestamp":1787668905335,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The excessive accumulation of extracellular matrix (ECM) is a key feature of liver fibrosis and the activated hepatic stellate cells (HSCs) are the major producer of ECM proteins. However, the precise mechanisms and target molecules that are involved in liver fibrosis remain unclear. In this study, we reported that activating transcription factor 3 (ATF3) was over-expressed in mice and human fibrotic livers, in activated HSCs and injured hepatocytes (HCs). Both in vivo and in vitro study have revealed that silencing ATF3 reduced the expression of pro-fibrotic genes and inhibited the activation of HSCs, thus alleviating the extent of liver fibrosis, indicating a potential protective role of ATF3 knockdown. However, ATF3 was not involved in either the apoptosis or proliferation of HCs. In addition, our data illustrated that increased nuclear localization of ATF3 promoted the transcription of fibrogenic genes and lnc-SCARNA10, which functioned as a novel positive regulator of TGF-\u03b2 signaling in liver fibrogenesis by recruiting SMAD3 to the promoter of these genes. Interestingly, further study also demonstrated that lnc-SCARNA10 promoted the expression of ATF3 in a TGF-\u03b2\/SMAD3-dependent manner, revealing a TGF-\u03b2\/ATF3\/lnc-SCARNA10 axis that contributed to liver fibrosis by activating HSCs. Taken together, our data provide a molecular mechanism implicating induced ATF3 in liver fibrosis, suggesting that ATF3 may represent a useful target in the development of therapeutic strategies for liver fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-020-03271-6","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T23:22:50Z","timestamp":1607901770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Zhemin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8916-556X","authenticated-orcid":false,"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"3271_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","volume":"121","author":"K Bottcher","year":"2017","unstructured":"Bottcher, K. & Pinzani, M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv. Drug Deliv. Rev. 121, 3\u20138 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3271_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2101-4","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription. Cell Death Dis. 10, 899 (2019).","journal-title":"Cell Death Dis."},{"key":"3271_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2411-6","volume":"11","author":"F Wandrer","year":"2020","unstructured":"Wandrer, F. et al. TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death Dis. 11, 212 (2020).","journal-title":"Cell Death Dis."},{"key":"3271_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1311-0","volume":"10","author":"D Jia","year":"2019","unstructured":"Jia, D. et al. SVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes. Cell Death Dis. 10, 71 (2019).","journal-title":"Cell Death Dis."},{"key":"3271_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.stem.2016.05.005","volume":"18","author":"M Rezvani","year":"2016","unstructured":"Rezvani, M. et al. In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis. Cell Stem Cell 18, 809\u2013816 (2016).","journal-title":"Cell Stem Cell"},{"key":"3271_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41575-019-0184-0","volume":"16","author":"K Ray","year":"2019","unstructured":"Ray, K. HAstening the development of liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 16, 455 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3271_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00018-012-1046-x","volume":"70","author":"F Zhang","year":"2013","unstructured":"Zhang, F., Kong, D., Lu, Y. & Zheng, S. Peroxisome proliferator-activated receptor-gamma as a therapeutic target for hepatic fibrosis: from bench to bedside. Cell Mol. Life Sci. 70, 259\u2013276 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"3271_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2575-0","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B\/PDGFR-beta pathway in hepatic stellate cells. Cell Death Dis. 11, 458 (2020).","journal-title":"Cell Death Dis."},{"key":"3271_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3271_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/thno.37301","volume":"10","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis. Theranostics 10, 36\u201349 (2020).","journal-title":"Theranostics"},{"key":"3271_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2596-8","volume":"11","author":"WY Sun","year":"2020","unstructured":"Sun, W. Y. et al. beta-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrix. Cell Death Dis. 11, 389 (2020).","journal-title":"Cell Death Dis."},{"key":"3271_CR12","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1074\/jbc.M116.773291","volume":"292","author":"K McDaniel","year":"2017","unstructured":"McDaniel, K. et al. The let-7\/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. J. Biol. Chem. 292, 11336\u201311347 (2017).","journal-title":"J. Biol. Chem."},{"key":"3271_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"3271_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone, F., Razori, M. V. & Roma, M. G. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol. Life Sci. 76, 99\u2013128 (2019).","journal-title":"Cell Mol. Life Sci."},{"key":"3271_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7752","volume":"6","author":"H Cui","year":"2015","unstructured":"Cui, H. et al. The stress-responsive gene ATF3 regulates the histone acetyltransferase Tip60. Nat. Commun. 6, 6752 (2015).","journal-title":"Nat. Commun."},{"key":"3271_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00551-0","volume":"273","author":"T Hai","year":"2001","unstructured":"Hai, T. & Hartman, M. G. The molecular biology and nomenclature of the activating transcription factor\/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273, 1\u201311 (2001).","journal-title":"Gene"},{"key":"3271_CR17","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1182\/blood-2009-03-213512","volume":"115","author":"M Gilchrist","year":"2010","unstructured":"Gilchrist, M. et al. A key role for ATF3 in regulating mast cell survival and mediator release. Blood 115, 4734\u20134741 (2010).","journal-title":"Blood"},{"key":"3271_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/nar\/gkp865","volume":"38","author":"KH Kim","year":"2010","unstructured":"Kim, K. H., Jeong, J. Y., Surh, Y. J. & Kim, K. W. Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes. Nucleic Acids Res. 38, 48\u201359 (2010).","journal-title":"Nucleic Acids Res."},{"key":"3271_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCRESAHA.109.196261","volume":"105","author":"T Suganami","year":"2009","unstructured":"Suganami, T. et al. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid\/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ. Res. 105, 25\u201332 (2009).","journal-title":"Circ. Res."},{"key":"3271_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"D De Nardo","year":"2013","unstructured":"De Nardo, D. et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 15, 152\u2013160 (2013).","journal-title":"Nat. Immunol."},{"key":"3271_CR21","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/blood-2005-07-2694","volume":"107","author":"M Janz","year":"2006","unstructured":"Janz, M. et al. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin\/Reed-Sternberg cells. Blood 107, 2536\u20132539 (2006).","journal-title":"Blood"},{"key":"3271_CR22","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/MCB.24.13.5721-5732.2004","volume":"24","author":"MG Hartman","year":"2004","unstructured":"Hartman, M. G. et al. Role for activating transcription factor 3 in stress-induced -cell apoptosis. Mol. Cell. Biol. 24, 5721\u20135732 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"3271_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature08996","volume":"465","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465, 368\u2013372 (2010).","journal-title":"Nature"},{"key":"3271_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2017.03.023","volume":"67","author":"JY Kim","year":"2017","unstructured":"Kim, J. Y. et al. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. J. Hepatol. 67, 349\u2013359 (2017).","journal-title":"J. Hepatol."},{"key":"3271_CR25","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/j.1742-4658.2010.07646.x","volume":"277","author":"IU Koh","year":"2010","unstructured":"Koh, I. U. et al. AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells. FEBS J. 277, 2304\u20132317 (2010).","journal-title":"FEBS J."},{"key":"3271_CR26","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.116.024599","volume":"135","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by suppressing MAP2K3-p38 signaling. Circulation 135, 2041\u20132057 (2017).","journal-title":"Circulation"},{"key":"3271_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2015.01.026","volume":"32","author":"A Thien","year":"2015","unstructured":"Thien, A. et al. TSC1 activates TGF-beta-Smad2\/3 signaling in growth arrest and epithelial-to-mesenchymal transition. Dev. Cell 32, 617\u2013630 (2015).","journal-title":"Dev. Cell"},{"key":"3271_CR28","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"LY Tang","year":"2017","unstructured":"Tang, L. Y. et al. Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J. Biol. Chem. 292, 4302\u20134312 (2017).","journal-title":"J. Biol. Chem."},{"key":"3271_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777","volume":"21","author":"K Palumbo-Zerr","year":"2015","unstructured":"Palumbo-Zerr, K. et al. Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis. Nat. Med. 21, 150\u2013158 (2015).","journal-title":"Nat. Med."},{"key":"3271_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S1097-2765(03)00109-6","volume":"11","author":"Y Kang","year":"2003","unstructured":"Kang, Y., Chen, C. R. & Massague, J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915\u2013926 (2003).","journal-title":"Mol. Cell"},{"key":"3271_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13498","volume":"7","author":"X Wu","year":"2016","unstructured":"Wu, X. et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat. Commun. 7, 13498 (2016).","journal-title":"Nat. Commun."},{"key":"3271_CR32","doi-asserted-by":"crossref","unstructured":"Su, J. et al. TGF-beta orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature 577, 566\u2013571 (2020).","DOI":"10.1038\/s41586-019-1897-5"},{"key":"3271_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1164\/rccm.201812-2313ED","volume":"200","author":"D Jiang","year":"2019","unstructured":"Jiang, D. & Liang, J. A long noncoding RNA links TGF-beta signaling in lung fibrosis. Am. J. Respir. Crit. Care Med. 200, 123\u2013125 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3271_CR34","doi-asserted-by":"crossref","unstructured":"Wang, P. et al. Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-beta\/Smad3 pathway. Sci. Transl Med. 10, eaat2039 (2018).","DOI":"10.1126\/scitranslmed.aat2039"},{"key":"3271_CR35","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.7150\/thno.32935","volume":"9","author":"K Zhang","year":"2019","unstructured":"Zhang, K. et al. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics 9, 3622\u20133638 (2019).","journal-title":"Theranostics"},{"key":"3271_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00204-4","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways. Nat. Commun. 8, 144 (2017).","journal-title":"Nat. Commun."},{"key":"3271_CR37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 24, 848\u2013862 (2016).","journal-title":"Cell Metab."},{"key":"3271_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature 556, 501\u2013504 (2018).","journal-title":"Nature"},{"key":"3271_CR39","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood-2013-06-510909","volume":"123","author":"ND Boespflug","year":"2014","unstructured":"Boespflug, N. D. et al. ATF3 is a novel regulator of mouse neutrophil migration. Blood 123, 2084\u20132093 (2014).","journal-title":"Blood"},{"key":"3271_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.2557","volume":"18","author":"W Hoetzenecker","year":"2011","unstructured":"Hoetzenecker, W. et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat. Med. 18, 128\u2013134 (2011).","journal-title":"Nat. Med."},{"key":"3271_CR41","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.7150\/thno.32710","volume":"9","author":"X-y Pan","year":"2019","unstructured":"Pan, X.-y et al. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin\/NFAT3 signaling. Theranostics 9, 4308\u20134323 (2019).","journal-title":"Theranostics"},{"key":"3271_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14289","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou, J., Edgar, B. A. & Boutros, M. ATF3 acts as a rheostat to control JNK signalling during intestinal regeneration. Nat. Commun. 8, 14289 (2017).","journal-title":"Nat. Commun."},{"key":"3271_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2323-5","volume":"11","author":"K Zhang","year":"2020","unstructured":"Zhang, K. et al. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 11, 132 (2020).","journal-title":"Cell Death Dis."},{"key":"3271_CR44","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.7150\/thno.36942","volume":"9","author":"K Zhang","year":"2019","unstructured":"Zhang, K. et al. The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition. Theranostics 9, 7566\u20137582 (2019).","journal-title":"Theranostics"},{"key":"3271_CR45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/febs.14045","volume":"284","author":"Z Shi","year":"2017","unstructured":"Shi, Z. et al. The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-kappaB-dependent manner. FEBS J. 284, 1096\u20131109 (2017).","journal-title":"FEBS J."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03271-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T11:01:35Z","timestamp":1670238095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["3271"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03271-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1066"}}